Report of Foreign Issuer (6-k)
May 12 2017 - 1:26PM
Edgar (US Regulatory)
FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For
period ending
11 May
2017
GlaxoSmithKline plc
(Name
of registrant)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or
will
file annual reports under cover Form 20-F or Form 40-F
Form
20-F x Form 40-F
--
Indicate
by check mark whether the registrant by furnishing the
information
contained in this Form is also thereby furnishing the
information
to the Commission pursuant to Rule 12g3-2(b) under the
Securities
Exchange Act of 1934.
Yes
No x
BLOCK LISTING SIX MONTHLY RETURN
Information
provided on this form must be typed or printed electronically and
provided to an ris.
Date:
12 May 2017
Name of
applicant:
|
GlaxoSmithKline
plc
|
Name of
scheme:
|
GlaxoSmithKline
Share Option Plan - Ordinary Shares
|
Period
of return:
|
From:
|
1
November 2016
|
To:
|
30
April 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
3,530,802
|
Plus:
The amount by which the block scheme(s) has been increased since
the date of the last return (if any increase has been applied
for):
|
2,142,952
1
|
Less:
Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G):
|
1,569,653
|
Equals:
Balance under scheme(s) not yet issued/allotted at end of
period:
|
4,104,101
|
1
This figure includes an adjustment of +142,952 unallotted
securities that were allotted under the GlaxoSmithKline plc 2009
Deferred Annual Bonus Plan but originally debited from the balance
for this Scheme.
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information
provided on this form must be typed or printed electronically and
provided to an ris.
Date:
12 May 2017
Name of
applicant:
|
GlaxoSmithKline
plc
|
Name of
scheme:
|
GlaxoSmithKline
Share Option Plan - ADS
|
Period
of return:
|
From:
|
1
November 2016
|
To:
|
30
April 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
9,349,738
|
Plus:
The amount by which the block scheme(s) has been increased since
the date of the last return (if any increase has been applied
for):
|
0
|
Less:
Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G):
|
553,924
|
Equals:
Balance under scheme(s) not yet issued/allotted at end of
period:
|
8,795,814
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information
provided on this form must be typed or printed electronically and
provided to an ris.
Date:
12 May 2017
Name of
applicant:
|
GlaxoSmithKline
plc
|
Name of
scheme:
|
Glaxo
Wellcome UK Share Option Scheme
|
Period
of return:
|
From:
|
1
November 2016
|
To:
|
30
April 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
5,119,750
|
Plus:
The amount by which the block scheme(s) has been increased since
the date of the last return (if any increase has been applied
for):
|
0
|
Less:
Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G):
|
0
|
Equals:
Balance under scheme(s) not yet issued/allotted at end of
period:
|
5,119,750
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information
provided on this form must be typed or printed electronically and
provided to an ris.
Date:
12 May 2017
Name of
applicant:
|
GlaxoSmithKline
plc
|
Name of
scheme:
|
Glaxo
Wellcome International Share Option Scheme
|
Period
of return:
|
From:
|
1
November 2016
|
To:
|
30
April 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
13,267,156
|
Plus:
The amount by which the block scheme(s) has been increased since
the date of the last return (if any increase has been applied
for):
|
0
|
Less:
Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G):
|
0
|
Equals:
Balance under scheme(s) not yet issued/allotted at end of
period:
|
13,267,156
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information
provided on this form must be typed or printed electronically and
provided to an ris.
Date:
12 May 2017
Name of
applicant:
|
GlaxoSmithKline
plc
|
Name of
scheme:
|
Glaxo
Wellcome 1999 Share Option Plan
|
Period
of return:
|
From:
|
1
November 2016
|
To:
|
30
April 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
1,040,000
|
Plus:
The amount by which the block scheme(s) has been increased since
the date of the last return (if any increase has been applied
for):
|
0
|
Less:
Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G):
|
0
|
Equals:
Balance under scheme(s) not yet issued/allotted at end of
period:
|
1,040,000
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information
provided on this form must be typed or printed electronically and
provided to an ris.
Date:
12 May 2017
Name of
applicant:
|
GlaxoSmithKline
plc
|
Name of
scheme:
|
SmithKline
Beecham 1989 Executive Share Option Plan - Approved - Ordinary
Shares
|
Period
of return:
|
From:
|
1
November 2016
|
To:
|
30
April 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
163,606
|
Plus:
The amount by which the block scheme(s) has been increased since
the date of the last return (if any increase has been applied
for):
|
0
|
Less:
Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G):
|
0
|
Equals:
Balance under scheme(s) not yet issued/allotted at end of
period:
|
163,606
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information
provided on this form must be typed or printed electronically and
provided to an ris.
Date:
12 May 2017
Name of
applicant:
|
GlaxoSmithKline
plc
|
Name of
scheme:
|
SmithKline
Beecham 1989 Executive Share Option Plan - Unapproved -
ADS
|
Period
of return:
|
From:
|
1
November 2016
|
To:
|
30
April 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
275,420
|
Plus:
The amount by which the block scheme(s) has been increased since
the date of the last return (if any increase has been applied
for):
|
0
|
Less:
Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G):
|
0
|
Equals:
Balance under scheme(s) not yet issued/allotted at end of
period:
|
275,420
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information
provided on this form must be typed or printed electronically and
provided to an ris.
Date:
12 May 2017
Name of
applicant:
|
GlaxoSmithKline
plc
|
Name of
scheme:
|
SmithKline
Beecham 1989 Executive Share Option Plan - Unapproved -
Ordinary
|
Period
of return:
|
From:
|
1
November 2016
|
To:
|
30
April 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
100,000
|
Plus:
The amount by which the block scheme(s) has been increased since
the date of the last return (if any increase has been applied
for):
|
0
|
Less:
Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G):
|
0
|
Equals:
Balance under scheme(s) not yet issued/allotted at end of
period:
|
100,000
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information
provided on this form must be typed or printed electronically and
provided to an ris.
Date:
12 May 2017
Name of
applicant:
|
GlaxoSmithKline
plc
|
Name of
scheme:
|
GlaxoSmithKline
Savings Related Share Option Scheme
|
Period
of return:
|
From:
|
1
November 2016
|
To:
|
30
April 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
2,742,626
|
Plus:
The amount by which the block scheme(s) has been increased since
the date of the last return (if any increase has been applied
for):
|
0
|
Less:
Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G):
|
0
|
Equals:
Balance under scheme(s) not yet issued/allotted at end of
period:
|
2,742,626
(the GlaxoSmithKline Savings Related Share Option Scheme has now
expired. The balance of 2,742,626 un-allotted shares under this
Scheme has therefore lapsed)
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information
provided on this form must be typed or printed electronically and
provided to an ris.
Date:
12 May 2017
Name of
applicant:
|
GlaxoSmithKline
plc
|
Name of
scheme:
|
GlaxoSmithKline
plc Share Save Plan 2012
|
Period
of return:
|
From:
|
1
November 2016
|
To:
|
30
April 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
239,107
|
Plus:
The amount by which the block scheme(s) has been increased since
the date of the last return (if any increase has been applied
for):
|
2,000,000
|
Less:
Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G):
|
603,782
|
Equals:
Balance under scheme(s) not yet issued/allotted at end of
period:
|
1,635,325
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
BLOCK LISTING SIX MONTHLY RETURN
Information
provided on this form must be typed or printed electronically and
provided to an ris.
Date:
12 May 2017
Name of
applicant:
|
GlaxoSmithKline
plc
|
Name of
scheme:
|
GlaxoSmithKline
plc 2009 Deferred Annual Bonus Plan
|
Period
of return:
|
From:
|
1
November 2016
|
To:
|
30
April 2017
|
Balance
of unallotted securities under scheme(s) from previous
return:
|
0
|
Plus:
The amount by which the block scheme(s) has been increased since
the date of the last return (if any increase has been applied
for):
|
600,000
|
Less:
Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G):
|
399,929
1
|
Equals:
Balance under scheme(s) not yet issued/allotted at end of
period:
|
200,071
|
1
This figure includes an adjustment of +142,952 allotted
securities that were allotted under this Scheme but originally
debited from the balance for the block listing under the
GlaxoSmithKline Share Option Plan - Ordinary Shares.
|
Name of
contact:
|
Victoria
Whyte
|
Telephone
number of contact:
|
020
8047 5000
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: May
12, 2017
|
|
|
|
|
By: VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|
GSK (NYSE:GSK)
Historical Stock Chart
From Sep 2024 to Oct 2024
GSK (NYSE:GSK)
Historical Stock Chart
From Oct 2023 to Oct 2024